Guinea-Bissau vs Senegal: HIV-positive TB patients on ART (antiretroviral therapy)
Guinea-Bissau
74.0%
in 2024
Senegal
74.0%
in 2024
Guinea-Bissau rank
121st
Senegal rank
121st
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Guinea-Bissau
- Senegal
How they compare
Guinea-Bissau currently reports 74.0% against 74.0% in Senegal, a difference of 0.0%.
Across all 14 years both countries report, Senegal has been ahead every year.
Guinea-Bissau ranks 121st and Senegal ranks 121st of 144 countries.
Senegal has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Guinea-Bissau | Senegal | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 13.0% | 32.0% | 19.0% | Senegal |
| 2010s | 40.3% | 85.5% | 45.2% | Senegal |
| 2020s | 71.4% | 90.8% | 19.4% | Senegal |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Guinea-Bissau or Senegal?
- Guinea-Bissau, at 74.0% against 74.0% in Senegal as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Guinea-Bissau and Senegal?
- 0.0%, with Guinea-Bissau ahead.
- How many years of comparable data are there for Guinea-Bissau and Senegal?
- 14 years are reported by both, from 2007 to 2024.
- How do Guinea-Bissau and Senegal rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Guinea-Bissau ranks 121st and Senegal ranks 121st of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.